vasculitis activity
Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis
9
Neutrophil to lymphocyte ratio at diagnosis can estimate vasculitis activity and poor prognosis in patients with ANCA-associated vasculitis: a retrospective study
7
Delta Neutrophil Index Is Associated with Vasculitis Activity and Risk of Relapse in ANCA Associated Vasculitis
9
Granulomatosis with polyangiitis: a 17 year experience from a tertiary care hospital in Pakistan
6
Comparison between optical coherence tomography angiography and fluorescein angiography findings in retinal vasculitis
5
IgG4:IgG RNA ratio differentiates active disease from remission in granulomatosis with polyangiitis: a new disease activity marker? A cross sectional and longitudinal study
11
Aberrant cytokine pattern of the nasal mucosa in granulomatosis with polyangiitis
9
Plasma complement factor H is associated with disease activity of patients with ANCA associated vasculitis
9
Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom
10
Platelet/lymphocyte ratio and mean platelet volume in patients with granulomatosis with polyangiitis
6
High mobility group box 1 contributes to anti myeloperoxidase antibody induced glomerular endothelial cell injury through a moesin dependent route
11
Long term outcome of patients with ANCA associated vasculitis treated with plasma exchange: a retrospective, single centre study
6
Eosinophilic Granulomatosis with Polyangiitis: Experiences in Korean Patients
8
Cutaneous vasculitis: An etiological and clinicopathological study
6
Vol 24, No 1 (2014)
7
CMR in inflammatory vasculitis
14
Myositis, Vasculitis, Hepatic Dysfunction in Adult-Onset Still's Disease
5
Cerebral rheumatoid vasculitis: a case report
5
Clinical Management of Uveitis in Systemic Rheumatic Autoimmune Diseases in Adults
10
Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
7